Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Baxter
Medtronic
Mallinckrodt
Express Scripts

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

Egalet Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for EGALET, and when can generic versions of EGALET drugs launch?

EGALET has five approved drugs.

There are three US patents protecting EGALET drugs.

There are thirty-six patent family members on EGALET drugs in twenty-one countries.

Summary for Egalet
International Patents:36
US Patents:3
Tradenames:3
Ingredients:1
NDAs:5
Patent Litigation for Egalet: See patent lawsuits for Egalet

Drugs and US Patents for Egalet

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Egalet TIVORBEX indomethacin CAPSULE;ORAL 204768-002 Feb 24, 2014 RX Yes Yes 8,992,982   Start Trial Y   Start Trial
Egalet INDOCIN indomethacin CAPSULE;ORAL 016059-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Egalet INDOCIN indomethacin SUSPENSION;ORAL 018332-001 Oct 10, 1985 RX Yes Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Egalet

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Egalet INDOCIN SR indomethacin CAPSULE, EXTENDED RELEASE;ORAL 018185-001 Feb 23, 1982 4,173,626   Start Trial
Egalet INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984 3,849,549   Start Trial
Egalet INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984 3,644,630   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
AstraZeneca
Colorcon
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.